Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker AGIO
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | Sarah Gheuens Chief Medical Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 7,866 | $37.69 | $296.5K Sale | Form 4 ↗ |
| Oct 22, 2026 | Sarah Gheuens Chief Medical Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 500 | $37.52 | $18.8K Sale | Form 4 ↗ |
| Oct 21, 2026 | Sarah Gheuens Chief Medical Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 1,489 | $37.53 | $55.9K Sale | Form 4 ↗ |
| Aug 4, 2026 | Sarah Gheuens Chief Medical Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 30,000 | $30.48 | $914.4K Sale | Form 4 ↗ |
| Jul 1, 2026 | Sarah Gheuens Chief Medical Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 4,007 | $37.56 | $150.5K Sale | Form 4 ↗ |
| Apr 2, 2026 | James William Burns Chief Legal Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 3,280 | $34.71 | $113.8K Sale | Form 4 ↗ |
| Apr 2, 2026 | Sarah Gheuens Chief Medical Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 2,940 | $34.71 | $102.0K Sale | Form 4 ↗ |
| Apr 2, 2026 | Cecilia Jones Chief Financial Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 3,141 | $34.71 | $109.0K Sale | Form 4 ↗ |
| Apr 2, 2026 | Tsveta Milanova Chief Commercial Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 3,262 | $34.71 | $113.2K Sale | Form 4 ↗ |
| Apr 2, 2026 | Krishnan Viswanadhan Chief Corp Dev & Strategy | AGIO Agios Pharmaceuticals, Inc. | Sale | 2,959 | $34.71 | $102.7K Sale | Form 4 ↗ |
| Apr 2, 2026 | Brian Goff Chief Executive Officer, Director | AGIO Agios Pharmaceuticals, Inc. | Sale | 6,596 | $34.71 | $228.9K Sale | Form 4 ↗ |
| Apr 2, 2026 | Brian Goff Chief Executive Officer, Director | AGIO Agios Pharmaceuticals, Inc. | Sale | 12,472 | $34.71 | $432.9K Sale | Form 4 ↗ |
| Mar 5, 2026 | Krishnan Viswanadhan Chief Corp Dev & Strategy | AGIO Agios Pharmaceuticals, Inc. | Sale | 2,959 | $27.80 | $82.3K Sale | Form 4 ↗ |
| Mar 3, 2026 | Theodore James Washburn Jr. Principal Accounting Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 5,272 | $28.88 | $152.3K Sale | Form 4 ↗ |
| Mar 2, 2026 | Brian Goff Chief Executive Officer, Director | AGIO Agios Pharmaceuticals, Inc. | Sale | 5,918 | $28.96 | $171.4K Sale | Form 4 ↗ |
| Mar 2, 2026 | Brian Goff Chief Executive Officer, Director | AGIO Agios Pharmaceuticals, Inc. | Sale | 8,267 | $28.96 | $239.4K Sale | Form 4 ↗ |
| Mar 2, 2026 | Brian Goff Chief Executive Officer, Director | AGIO Agios Pharmaceuticals, Inc. | Sale | 3,870 | $28.96 | $112.1K Sale | Form 4 ↗ |
| Mar 2, 2026 | James William Burns Chief Legal Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 1,163 | $28.96 | $33.7K Sale | Form 4 ↗ |
| Mar 2, 2026 | James William Burns Chief Legal Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 1,187 | $28.96 | $34.4K Sale | Form 4 ↗ |
| Mar 2, 2026 | James William Burns Chief Legal Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 1,681 | $28.96 | $48.7K Sale | Form 4 ↗ |
| Mar 2, 2026 | James William Burns Chief Legal Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 1,187 | $28.96 | $34.4K Sale | Form 4 ↗ |
| Mar 2, 2026 | Sarah Gheuens Chief Medical Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 1,187 | $28.96 | $34.4K Sale | Form 4 ↗ |
| Mar 2, 2026 | Sarah Gheuens Chief Medical Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 1,681 | $28.96 | $48.7K Sale | Form 4 ↗ |
| Mar 2, 2026 | Sarah Gheuens Chief Medical Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 1,187 | $28.96 | $34.4K Sale | Form 4 ↗ |
| Mar 2, 2026 | Cecilia Jones Chief Financial Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 1,573 | $28.96 | $45.6K Sale | Form 4 ↗ |
| Mar 2, 2026 | Cecilia Jones Chief Financial Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 1,187 | $28.96 | $34.4K Sale | Form 4 ↗ |
| Mar 2, 2026 | Cecilia Jones Chief Financial Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 1,681 | $28.96 | $48.7K Sale | Form 4 ↗ |
| Mar 2, 2026 | Cecilia Jones Chief Financial Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 594 | $28.96 | $17.2K Sale | Form 4 ↗ |
| Mar 2, 2026 | Tsveta Milanova Chief Commercial Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 1,187 | $28.96 | $34.4K Sale | Form 4 ↗ |
| Mar 2, 2026 | Tsveta Milanova Chief Commercial Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 1,681 | $28.96 | $48.7K Sale | Form 4 ↗ |
| Mar 2, 2026 | Theodore James Washburn Jr. Principal Accounting Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 798 | $28.96 | $23.1K Sale | Form 4 ↗ |
| Mar 2, 2026 | Theodore James Washburn Jr. Principal Accounting Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 727 | $28.96 | $21.1K Sale | Form 4 ↗ |
| Mar 2, 2026 | Theodore James Washburn Jr. Principal Accounting Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 698 | $28.96 | $20.2K Sale | Form 4 ↗ |
| Jan 5, 2026 | Tsveta Milanova Chief Commercial Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 2,872 | $27.02 | $77.6K Sale | Form 4 ↗ |
| Dec 30, 2025 | James William Burns Chief Legal Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 2,932 | $27.09 | $79.4K Sale | Form 4 ↗ |
| Dec 30, 2025 | Brian Goff Chief Executive Officer, Director | AGIO Agios Pharmaceuticals, Inc. | Sale | 6,230 | $27.09 | $168.8K Sale | Form 4 ↗ |
| Dec 30, 2025 | Brian Goff Chief Executive Officer, Director | AGIO Agios Pharmaceuticals, Inc. | Sale | 12,473 | $27.09 | $337.9K Sale | Form 4 ↗ |
| Dec 30, 2025 | Sarah Gheuens Chief Medical Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 2,932 | $27.09 | $79.4K Sale | Form 4 ↗ |
| Dec 30, 2025 | Tsveta Milanova Chief Commercial Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 2,932 | $27.09 | $79.4K Sale | Form 4 ↗ |
| Dec 30, 2025 | Cecilia Jones Chief Financial Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 2,932 | $27.09 | $79.4K Sale | Form 4 ↗ |
| Nov 12, 2025 | David Scadden Director | AGIO Agios Pharmaceuticals, Inc. | Sale | 200 | $43.84 | $8,768 Sale | Form 4 ↗ |
| Nov 11, 2025 | Sarah Gheuens Chief Medical Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 2,454 | $43.78 | $107.4K Sale | Form 4 ↗ |
| Oct 30, 2025 | Sarah Gheuens Chief Medical Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 200 | $43.81 | $8,762 Sale | Form 4 ↗ |
| Oct 27, 2025 | Sarah Gheuens Chief Medical Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 3,302 | $43.92 | $145.0K Sale | Form 4 ↗ |
| Oct 8, 2025 | David Scadden Director | AGIO Agios Pharmaceuticals, Inc. | Sale | 200 | $41.00 | $8,200 Sale | Form 4 ↗ |
| Sep 30, 2025 | David Scadden Director | AGIO Agios Pharmaceuticals, Inc. | Sale | 200 | $40.00 | $8,000 Sale | Form 4 ↗ |
| Sep 26, 2025 | Cecilia Jones Chief Financial Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 3,651 | $36.77 | $134.2K Sale | Form 4 ↗ |
| Sep 5, 2025 | Theodore James Washburn Jr. Principal Accounting Officer | AGIO Agios Pharmaceuticals, Inc. | Sale | 8,546 | $36.87 | $315.1K Sale | Form 4 ↗ |
| Aug 27, 2025 | David Scadden Director | AGIO Agios Pharmaceuticals, Inc. | Sale | 200 | $40.00 | $8,000 Sale | Form 4 ↗ |
| Aug 8, 2025 | Brian Goff Chief Executive Officer, Director | AGIO Agios Pharmaceuticals, Inc. | Sale | 11,085 | $36.67 | $406.5K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:48 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances